《美股業績》道指成分股旅行家集團(TRV.US)季績勝預期
道指成分股,美國財險巨擘旅行家集團(TRV.US)公佈去年第四季業績。季度純利13.33億美元,按年升2%。每股季度攤薄純利5.37美元,經調整後爲5.2美元,高於市場預期的3.86美元。季度收入90.11億美元,按年升7%。其中淨保費收入79.95億美元,按年升10%。淨投資收益按年升9.8%至7.43億元。
公司表示,季內錄得的災難保險索賠主要涉及肯塔基州的龍捲風、多個州份的風暴及科羅拉多州山火。季內綜合成本率爲88%,按年升1.3個百分點。
旅行家集團昨日(20日)升3.2%報165.18美元,盤中見169.49美元歷史新高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.